WHAT'S KNOWN ON THIS SUBJECT: The incidence of cerebral palsy is dependent on the gestational age in very preterm infants and risk factors have been identified for term infants. The risk has also proved to be greater among late preterm births compared with term.
The preterm birth rate has increased markedly during the past decades, mainly due to the increase in late preterm (LP) births in a number of countries, especially in the United States. 1,2 LP infants are defined as infants born between gestation weeks 34 +0 and 36 +6 ; they account for more than 70% of all prematurely born infants in the United States. 2, 3 This group has commonly been referred to as "near term" infants, but the description has been felt inappropriate in that it underestimates the risks of these preterm infants. 3 Moderately preterm (MP) (32 +0 -33 +6 gestation weeks) and LP infants comprise .80% of all preterm births together. 4, 5 The rate of preterm delivery in Finland has not increased significantly, in contrast to trends in other countries. 6 The brain of the MPand LP infant is more vulnerable to injury than the brain of full-term infants. The weight of the brain at 34 weeks of gestation is only 65% of the term brain and the total brain volume increases linearly with increasing gestational age (GA). 7 Morbidity and mortality levels among MP and LP infants are higher compared with term. [8] [9] [10] In the United States and the United Kingdom, LP infants have been found to have poorer neurodevelopmental outcomes than term infants, 4, [11] [12] [13] [14] [15] [16] [17] [18] but some studies did not find more neurodevelopmental problems among healthy LP children. 19 Outcome data may vary due to diverse conditions in different countries and populations. Thus, more data and large prospective studies are needed. No statistics on the long-term outcome of MP and LP infants have been reported from the Nordic countries.
Cerebral palsy (CP) is defined as a disorder of motor behavior attributable to disturbances in the developing fetal or infant brain. 20 According to the standard guideline, the diagnosis of CP is based on medical history, imaging (ultrasound, high-resolution magnetic resonance imaging [MRI] ) data, and clinical multidisciplinary evaluations in the pediatric neurology units. The CP incidence has been shown to be dependent on GA in very preterm (VP) infants. 21 Also in LP infants, the risk has been almost threefold compared with the term group. 22 Risk factors of CP have been identified for term infants, 23 but less for MP and LP infants.
Our aim was to compare the CP incidence among LP and MP infants to that among VP and term infants and to identify risk factors for CP in the Finnish population. The hospitalizations, reimbursements for medicine expenses, and disability allowances due to CP were established to study the burden of CP. Also the effect of time period on the incidence of CP was studied.
METHODS
This national register study population consisted of all, a total of 1 039 263 infants born in Finland from 1991 to 2008. The baseline characteristic data were collected from the Medical Birth Register (MBR), maintained by the National Institutes of Health and Welfare (NIHW). This register contains information on the mother' s health and interventions during pregnancy and delivery and on the infant' s health and procedures undergone during the first 7 days of life. It collects data on all live births and stillbirths from the GA of 22 +0 weeks onward and/or birth weight of at least 500 g.
Data on deaths were obtained from the Cause-of-Death Register maintained by Statistics Finland and data on major structural anomalies and chromosomal defects 24 from the Register of Congenital Malformation, maintained by the NIHW. Infants who died before the age of 1 year (n = 2613), children with at least 1 major congenital anomaly (n =13 007), and cases lacking data on GA were excluded (n = 5520).
The remaining 1 018 302 infants (98.0% of all) comprised the cohort for analysis. Infants were followed up to 7 years of age or to 2009. The study population was divided into subgroups, the gestationweek categories being VP (#32 +0 weeks, n = 6347), MP (32   +0   -33 +6 weeks, n = 6799), LP (34   +0   -36 +6 weeks, n = 39 932), and term ($37 weeks, n = 965 224). The GA was based on early pregnancy ultrasound and correction of GA was made if the ultrasound-based estimation had a discrepancy of 5 to 7 days or more compared with menstrual anamnesis.
Pregnancy-and delivery-related diagnoses of mothers were collected from the Hospital Discharge Register (HDR). This is also maintained by the NIHW and contains information on admission and discharge dates, diagnoses, and surgical procedures. Since 1998, the data also cover hospital outpatient visits. Diagnoses were coded according to the International Classification of Diseases, Ninth Revision (ICD-9) in 1987 to 1995 and according to the 10th Revision (ICD-10) from 1996. Three different time periods were compared: 1991 to 1995, 1996 to 2001, and 2002 to 2008. These periods were chosen because the classification system of disease was changed in 1996 from ICD-9 to ICD-10 and the MBR changed the data collection forms 1.10.1990 and 1.1.1996.
Preeclampsia was defined as high blood pressure, edemas, and proteinuria by ICD-10 codes O10 to O16 (ICD-9 codes 6420-6429). Premature rupture of membranes (PROM) was sought via ICD-10 codes O42.0 to O42.9 (ICD-9 codes 6581-6583) in the mothers' diagnoses. Pregnancy-related risk factors were the number of fetuses and their order, timing of birth, in vitro fertilization, and cervical cerclage. Resuscitation at birth included intubation, mechanical ventilation, and/or chest compressions. Phototherapy has been given according to guidelines depending on gestation weeks and some minor variance may exist in guidelines between hospitals. Respiratory distress syndrome (RDS) was diagnosed on the basis of typical changes in chest radiograph, excessive need of oxygen supply, and surfactant therapy. It was traced in the register with ICD-10 code P22.0 (ICD-9 code 769). Small for GA (SGA) infants were defined as those with a birth weight ,2 SDs below the mean weight for GA and large for GA infants as those with a birth weight .2 SDs over the mean weight for GA according to the Finnish genderspecific fetal growth curves. 25 Umbilical artery pH cutoff ,7.05 was used to define fetal acidemia. 26, 27 Only variables with good validity in the registerswerechosenfor theanalysis. 28, 29 Intracranial hemorrhage diagnosis was based on the head ultrasound or MRI findings and classified according to the Papile classification system. 30 MP and LP infants do not undergo routine head ultrasounds but infants with asphyxia and/or neurologic symptoms, and/or with need of intensive care are routinely examined with head ultrasound. Oneminute Apgar scores were included in the multivariate analysis, but 5-minute scores were excluded because it was found from the register only from 2004 onward. Information on maternal hypertension was available only in combination with preeclampsia. Mother' s diabetes included gestational diabetes, and type 1 and 2 diabetes. Neither data on chorioamnionitis nor antenatal viral infection was possible to define reliably according to registers. Infants were defined to be asphyxiated when they had a 1-minute Apgar score ,7 and needed intubation during delivery room resuscitation.
All inpatient and outpatient visits due to a CP diagnosis in public hospitals were registered according to the HDR. The diagnosis of CP in Finland is based on medical history, ultrasound and MRI data, and multidisciplinary evaluations in the pediatric neurology units of 20 secondary-level central hospitals and 5 tertiary-level university hospitals. CP is usually evident within first 2 years of life and almost always by the age of 3 to 4 years, and the diagnosis is included in the HDR as soon as it has been established. Information on special reimbursements and benefits for disability were collected from the register of the Social Insurance Institution of Finland. All data linkages were done by using unique personal identity codes anonymized by the authorities.
A case with CP was recorded if the individual was detected in the HDR and/or in the Reimbursement Register of the Social Insurance Institution with ICD-10 codes G80 to G83 in 1996 to 2008 and ICD-9 codes 342 to 344 in 1991 to 1995. Subtypes of CP were defined by topographic involvement (hemiplegia, diplegia, quadriplegia, and other types) and sought from registers with corresponding ICD codes (hemiplegia ICD-10 G80.2/ICD-9 343.1 and 343.4; diplegia G80.1/343.0; quadriplegia G80.0/343.2 and other types including the rest of CP diagnoses according to the baseline ICD code definitions).
Statistical Analysis
Characteristics of infants alive at age of 1 year and those of their mothers were described by meanswith SDs in the case of normal distributed continuous variables, by medians with interquartile range in skew distributed variables, and otherwise if variables were categorical by number of values with percentages. GA groups were compared for each other by Mann-Whitney test, x 2 test, or Fisher' s exact test (Tables 1, 2 , and 3). Risk factors for CP were sought by logistic regression analysis by using multivariate enter models for each GA group separately (Table 4 ). In enter model, all variables were entered simultaneously into the model separately for each gestational week class. Association of gestation weeks for CP was studied by adjusting a multivariate model by gestation week classes, term class as reference. Results were shown by odds ratios (ORs) with 95% confidence intervals (95% CIs) in modeling risk factors for CP. A large number of variables were included in the analysis, because in a large population, also less well-known predictors for CP can be detected. Statistical analyses were performed on IBM SPSS Statistics version 20.0.0 (IBM SPSS Statistics, IBM Corporation, Chicago, IL). P , .05 was considered statistically significant.
RESULTS
LP infants accounted for 75% and MP infants for 13% of all prematurely born infants in Finland during this study period. Characteristics of newborns and mothers are shown in Table 1 After combining the register data, 2242 CP cases were identified. The incidence of CP was 0.22%, and it decreased nonlinearly with increasing GA, and with time. The decrease by time was greatest in the VP group, and during the latest time period (ie, after 2001) ( Table 2 , Fig 1) . The analysis of CP subtypes showed that the proportion of diplegia cases was greatest in the VP group and of hemiplegia cases in the term group (Table 3) .
Birth during the earliest period, 1991 to 1995, 1-minute Apgar score ,7, and intracranial hemorrhage predicted CP in all GA categories in the logistic regression model (Table 4 ). Resuscitation at birth was associated with an increased risk in MP and LP groups and in the term group. SGA and antibiotic treatment during the first hospitalization seemed to predict an increased risk of CP in the LP and the term groups. PROM was associated with an increased and antenatal steroid treatment with a decreased risk of CP in the MP group. 
DISCUSSION
In this population the incidence and risk for CP were higher among MP and LP infants compared with those born at term. The burden of CP to the families of the MP and LP children, in terms of medicine expenses, is comparable with term-born babies. Also the need of disabilityallowance seems tobesignificantly less common in the MP and LP groups than in the VP cases. Birth at an earlier period, being SGA, and having asphyxia and intracranial hemorrhage emerged as significant predictors for CP, whereas antenatal corticosteroid therapy seemed toreducethe risk. Ourresultscanbeused in the counseling of parents and in planning guidelines for follow-up practices of MP and LP newborns.
The most prominent weakness of register studies is that recording practices may differ significantly among individuals, sites, and regions. The classification system of diseases was changed in 1996. Although diagnoses were converted to be identical, this change might have affected the diagnostic categories. Children born during the last years of the latest study period 2002 to 2008 had shorter follow-up time, which also may have influenced the decrease in CP risk compared with the earlier periods. However, the CP diagnosis was usually made by the age of 1.5 years. Data of 5-minute Apgar score were not available from the register during this study period and we used the 1-minute score, which is a relatively vague marker The duration of the allowance (years), Md (IQR)
The number of granted allowance periods, Md (IQR)
Diagnosis of CP from the HDR; reimbursements due to CP from the social insurance institution. Data include newborns alive at age of 1 year, followed to age of 7 years without major congenital anomalies, 1991-2008 (n = 1 018 302 for outcome. Recording practices for hypoxic-ischemic encephalopathy and multiorgan failure had substantial variance and, thus, could not be included in analysis.
Strengths of this study are reliable and comprehensive population-based register data and the substantial number of infants. The national health registers in Finland are well-established and validated. The MBR is a high-quality register coveringmorethan99.9%ofallbirths. 29, 31 The data quality, completeness, and accuracy of the HDR have been varied from satisfactory to very good in a systematic review. 28 Infants were followed to the age of 7 years, by which time the diagnosis of CP is generally made. CP diagnoses can be regarded as reliable, because they are made in public hospitals in specialized units of child neurology. The prevalence of congenital anomalies has been 2.2 times greater in infants born at 32 to 36 weeks of gestation compared with term infants, 32 which is a significant confounder when seeking perinatal risk factors. Here, as elsewhere, 33 all infants with major congenital anomalies were excluded.
The CP incidence was in accordance with the literature. 34 It was higher in the preterm groups compared with the term group and began to decrease clearly after 28 weeks of gestation. Small rates of CP at 24 and 25 weeks of gestation are probably due to small numbers of cases. In our study, the risk of CP was 5.12 (OR) in the MP compared with the term group. In the United States, the risk of CP has been threefold in LP subjects compared with children born at term, 22 whereas the risk in our population was 2.35 (OR) compared with term-born children. In the current study, the risk of CP decreased over time in all subgroups. The drop was greatest in the VP group, 
FIGURE 1
Incidences of cerebral palsy (n = 2242) per 100 000 births by age of 7 years by gestational age, birth years 1991-2008 (n = 1 018 302).
probably due to advances in perinatal and neonatal care. The prevalence of CP among MP infants also decreased in the European register study between 1980 and 1998. 35 In contrast, according to a recent systematic review and metaanalysis, the overall CP prevalence has remained constant in recent years. 36 SGA predicted the CP risk in the Finnish LP and term infants. In contrast, in a Swedish cohort of 334 cases with CP and 668 controls matched for gestation, gender, and delivery unit, SGA associated with CP in term, but not LP infants. 37 In their study, growth status was determined by using customized birth weight percentiles, based on the growth potential calculated for each infant, whereas we used population-based birth weight standards. The different study designs probably explain the conflicting results.
Resuscitation at birth and low Apgar score were significant risk factors for CP in this study, showingasphyxiaat birthto be a major cause of hypoxic ischemic brain injury, and of later motor disability. Efforts to prevent and treat asphyxia seem to be an effective means of preventing CP also in the MP and LP infants. Intracranial hemorrhage increased the risk of CP significantly in all subgroups. It is obvious, and also previously demonstrated, that brain injury visible in brain imaging correlates with the development of CP. 38 An antibiotic treatment appeared to predict a CP risk in groups from moderately preterm to term infants. Premature labor might be predisposed by infection and it is thus common practice to start antibiotic therapy for a premature newborn. Also, most infants who need intensive care are treated with antibiotics in cases of suspected sepsis. Thus, antibiotic treatment is rather a marker of the sickness of the infant than a causative factor for CP. Conversely, true sepsis was not a significant risk factor, possibly because of the small number of cases with a proven sepsis diagnosis. PROM was a predictor for CP in the MP group. PROM can be regarded as a relevant marker of chorioamnionitis in register studies. 39, 40 Instead, true incidence of chorioamnionitis, a well-known risk factor for CP, 41, 42 cannot be established in a register study by using the ICD-9 or ICD-10 diagnoses, because histologic or clinical confirmation is rarely available.
LP infants evince a higher neonatal morbidity compared with term-born infants, this including higher rates of RDS. 43 In the current study, RDS was associated with a decreased risk of CP in the LP group and ventilator treatment with an increased risk in the VP, LP, and term groups. Infants who needed mechanical ventilation for reasons other than RDS may have had other morbidities, such as asphyxia or infection, which might be more harmful to the developing brain than RDS only. Antenatal steroid treatment predicted a decreased risk of CP in MP infants. According to earlier national guidelines, mothers expected to deliver before 34 +0 weeks of gestation were treated with glucocorticoids. The updated guideline recommends antenatal glucocorticoid treatment to be administered later (ie, before 35 +0 weeks' gestation). 44 This change seems to be beneficial also in reducing the risk of CP in this group.
CONCLUSIONS
The incidence of CP increases nonlinearly with decreasing GA. LP and MP infants are at a significantly greater risk comparedwithterm infants.The risk has decreased in all GA groups over time. Asphyxia and intracranial hemorrhage emerge as the most prominent risk factors in all gestation week categories. Efforts to prevent and treat asphyxia are of prime importance in reducing the risk of CP. Antenatal steroid treatment appears to reduce the risk among MP infants. Guidelines for management and risk assessment need to be established for LP and MP infants.
